The eye provides novel insights into general health, as well as pathogenesis and development of systemic diseases. In the past decade, growing evidence has demonstrated that the eye's structure and function mirror multiple systemic health conditions, especially in cardiovascular diseases, neurodegenerative disorders and kidney impairments. This has given rise to the field of oculomics - the application of ophthalmic biomarkers to understand mechanisms, detect and predict systemic disease. This course summarizes current concepts and evidence in the field of oculomics, highlighting the progress that has been made, remaining challenges and the opportunities for future research.
Over 900 attended our event and we received amazing feedback!
Feedback from anonymous survey:
Loved the OCT examples!
This was fantastic! We need more lectures like this!
He was a great speaker. Clear and easy to follow.
Absolutely terrific!! Very interesting and relevant especially linking systemic/ retinal conditions with new technology and AI. Really speaks to the future of the profession. Please PLEASE more lectures like this!!! On this topic!
Unique perspective as to what is coming with Ai.
Excellent Lecture. Informative/ preparing a new foundation for coordination of care .
Love Dr. Pizzimenti!!
I would like to hear more about this technology.
Great lecture, supporting our current practice.
Interesting and unique topic!
Would love to have another lecture on this topic. Very well done and is super important to the future of the primary care role we have!!
Interesting to hear something new!
Such a great presentation overall.
Relevant topic and really interesting data and case studies.
He was fabulous! Can he lecture more, and more on this topic?
Speaker: Joseph Pizzimenti, O.D.
Moderator: Dr. Jennifer Stewart
COPE ID: 102708-GO
Category: General Optometry
This event is COPE approved for 1 hour CE credit.
Optomed is a Finnish medical technology company and one of the leading providers globally of handheld fundus cameras and screening software. Our mission is to prevent blindness by improving access to eye screening globally. Learn more here.